Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Q4 2018 Moderna Inc Earnings Call Transcript

Mar 06, 2019 / 01:00PM GMT
Release Date Price: $20.65 (-3.37%)
Operator

Good morning, and welcome to the Moderna Corporate Update and 2018 Financial Review Conference Call. (Operator Instructions) Please be advised that the call is being recorded.

At this time, I would like to turn the call over to Laura Schneck, Investor Relations at Moderna. Please proceed.

Laura Schneck
Moderna, Inc. - IR & Associate Director

Thank you, operator. Good morning, and welcome to the Moderna Corporate Update and 2018 Financial Review Conference Call.

This morning, we issued a press release that outlines the topics of events discussed today. You can access the press release as well as the slides that we'll be reviewing by going to the Investors section of our website at modernatx.com.

Today, on this conference call, we have Stéphane Bancel, our Chief Executive Officer; Tal Zaks, our Chief Medical Officer; and Lorence Kim, our Chief Financial Officer. Stephen Hoge, our President, will also join us when we open up for Q&A at the end.

Before we begin, I would like to remind everyone that this conference

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot